Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 9 | 3 | −6 |
| Shares | 134.8K | 37.3K | −97.5K (−72.3%) |
| Value | $264.6K | $49.2K | −$215.4K (−81.4%) |
New holders (0)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (6)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| SG Americas Securities, LLC | 16,899 | $33.0K |
| Two Sigma Securities, LLC | 16,468 | $32.3K |
| Virtu Financial LLC | 15,603 | $31.0K |
| Goldman Sachs Group Inc | 12,429 | $24.4K |
| Two Sigma Investments, LP | 11,772 | $23.1K |
| UBS Group AG | 485 | $951 |